Prime-Global-Welcomes-Earthware-v2.jpg

Prime Global acquires award-winning digital agency earthware, enhancing digital and technology expertise

Prime Global, a recognised global leader in medical communications, evidence and access, and patient engagement, has acquired earthware, an award-winning creative digital agency that creates life-changing solutions to real world healthcare problems. earthware joins Prime Global in supporting pharma and biotech clients at every step of the healthcare journey; their industry-leading technology expertise will complement Prime Global’s scientific heritage and proven delivery, enhancing and expanding Prime Global’s existing digital capabilities.

read more >>
Prime GlobalPrime Global acquires award-winning digital agency earthware, enhancing digital and technology expertise
18014248_ESG_Social_v1_FB_Twitter_LinkedIn.jpg

Ensuring sustainable business travel for our people

At Prime Global, we are passionate about ensuring our operations are sustainable. We are proud to be working together with travel supplier Gray Dawes, in partnership with Forest Carbon, to provide our people with an international carbon offset programme for all business travel.

read more >>
Prime GlobalEnsuring sustainable business travel for our people
pexels-tristan-le-1642883-scaled.jpg

Dementia and patient engagement: not as incompatible as you might think

An estimated 57.4 million people live with dementia worldwide, (1) and unfortunately, clinical trials for dementia treatments have resulted in few pharmacotherapies – none of them curative. (2) (3) (4) For World Alzheimer’s Day, Prime Patient explore how Pharma can collaborate with people living with dementia to optimise the industry’s dementia research and patient community support.

read more >>
Prime GlobalDementia and patient engagement: not as incompatible as you might think
Disability-inclusion-re-size-for-web.jpg

Disability inclusion in clinical trials and equity in outcomes

Many agree that disability inclusion in clinical trials is a worthy pursuit, but the historical significance and future impact of pursuing this goal is relatively unexplored. Here, we peel back the layers of this vital mission.

read more >>
Prime GlobalDisability inclusion in clinical trials and equity in outcomes
walking-challenge-2022-scaled.jpg

Virtually walking South America in support of Rainforest Action Network

At Prime Global, we are committed to supporting charities and causes that have a direct impact on our communities. This year, we organised the Prime Global Walking Challenge, a virtual walking challenge as part of our ESG initiative to help raise money for the Rainforest Action Network.

read more >>
Prime GlobalVirtually walking South America in support of Rainforest Action Network
Patient-Centricity-Engagement-conference.png

Not just a buzzword: how Pharma and advocacy leaders are effecting meaningful patient centricity

On May 24th, the Prime Patient team was fortunate to have a spot at 2022’s Patient Centricity and Engagement Conference, hosted in London, England. With a veritable smorgasbord of topics up for discussion, we were spoiled for choice! Here we summarise some highlights from the day, kicking off with tips on strengthening patient advocacy collaboration. 

read more >>
Prime GlobalNot just a buzzword: how Pharma and advocacy leaders are effecting meaningful patient centricity
WHD2022-1200x350-EN-1.jpg

Haemophilia awareness: building trusted relationships between patients and industry

Haemophilia is a lifelong genetic disorder characterised by excessive bleeding.(1) Despite the existence of treatments for haemophilia, the condition continues to have major impacts on quality of life, for example in the areas of pain (acute and chronic), joint mobility, and physical function.(1) To mark World Haemophilia Day on 17 April, Prime Patient partnered with sister agency HCD Economics, a consultancy specialising in haemophilia patient research, and haemophilia advocate Laurence Woollard to better understand the existing relationship between patients and industry and how meaningful improvements can be made to the lives of people living with haemophilia (PwH).

read more >>
Prime GlobalHaemophilia awareness: building trusted relationships between patients and industry
shutterstock_1074052664_2500-1.jpg

Patient engagement in rare mutation cancers

Patient advocacy and engagement are important no matter the disease area, whether it’s a common condition or one that few have heard of. Following the recent celebration of Rare Disease Day, let’s take a closer look at patient engagement in rare mutation cancers. 

read more >>
Prime GlobalPatient engagement in rare mutation cancers
18010354_Rare-disease-day_posts_v3_1.png

Amplifying the Patient Voice in Rare Diseases

Medical publishing is evolving beyond plain language summaries to provide insightful, patient-centred resources to change the course of pharmaceutical research for the better. For patients with rare diseases especially, this could be just what the doctor ordered, writes Olivia Kersey, Patient Engagement Strategist with Prime Patient.

read more >>
Prime GlobalAmplifying the Patient Voice in Rare Diseases
Support-Pledge-Strapline-1920x1080_ENGLISH.png

Rare reflections: has the pandemic helped or hindered patient engagement and research for rare diseases?

Emma Sutcliffe, SVP Patient Insights and Solutions, Prime Patient shares her reflections about whether the pandemic has helped or hindered patient engagement and research for rare diseases.

read more >>
Prime GlobalRare reflections: has the pandemic helped or hindered patient engagement and research for rare diseases?
18010354_WHO_post_illustrations_v5-02.png

How to make 2022 the best year yet for patient engagement

Olivia Kersey, Patient Engagement Strategist, outlines what we can learn from 2021 to optimise patient engagement strategy and implementation in 2022.

While there would be no such thing as the pharmaceutical industry without patients, it’s only in recent years that collaboration with patients has started to enter the mainstream. While 2021 was a good year for patient engagement, 2022 can be both bigger and better.

read more >>
Prime GlobalHow to make 2022 the best year yet for patient engagement
shutterstock_1689338008_2500.jpg

Patient authorship survey poster presented at ISMPP 2022

The Prime Patient team are proud to have had a poster accepted for presentation at the 2022 European meeting of ISMPP (International Society for Medical Publication Professionals), held virtually on 25-26 January. The poster, one of five accepted across Prime Global, presents the results of an internal survey that aimed to identify barriers and solutions to working with patient authors in medical publications.

read more >>
Prime GlobalPatient authorship survey poster presented at ISMPP 2022
18010362_Welcome-HCD-economics_v2-01.jpg

Prime Global acquires HCD Economics, creating an innovative evidence-generating, HEOR, value & communications group

Prime Global, a recognised global leader in medical communications and market access, has strengthened its Evidence, Access, and Patient Practice with the acquisition of HCD Economics, an academically aligned organisation focusing on health economics and outcomes research (HEOR) and real-world evidence (RWE). HCD will work closely with Prime Global’s highly experienced medical communications agencies and specialist consultancies, including market access consultancy, Prime Access, and patient engagement experts, Prime Patient, to deliver integrated evidence-led services.

read more >>
Prime GlobalPrime Global acquires HCD Economics, creating an innovative evidence-generating, HEOR, value & communications group